163 related articles for article (PubMed ID: 22783696)
1. Rectal adenocarcinoma: proposal for a model based on pretreatment prognostic factors.
Cabanillas F; Nieves-Plaza M; Quevedo G; Echenique IA
P R Health Sci J; 2012 Jun; 31(2):52-8. PubMed ID: 22783696
[TBL] [Abstract][Full Text] [Related]
2. Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
Margalit O; Mamtani R; Kopetz S; Yang YX; Lawrence YR; Abu-Gazala S; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
Oncologist; 2019 Aug; 24(8):e671-e676. PubMed ID: 30696723
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
4. Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients.
Tarantino I; Warschkow R; Worni M; Merati-Kashani K; Köberle D; Schmied BM; Müller SA; Steffen T; Cerny T; Güller U
Br J Cancer; 2012 Jul; 107(2):266-74. PubMed ID: 22735902
[TBL] [Abstract][Full Text] [Related]
5. Association between smoking at diagnosis and cause-specific survival in patients with rectal cancer: Results from a population-based analysis of 10,794 cases.
Sharp L; McDevitt J; Brown C; Carsin AE; Comber H
Cancer; 2017 Jul; 123(13):2543-2550. PubMed ID: 28297071
[TBL] [Abstract][Full Text] [Related]
6. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Pretreatment Serum CA199 in Patients with Locally Advanced Rectal Cancer Treated with CRT Followed by TME with Normal Pretreatment Carcinoembryonic Antigen Levels.
Huang D; Lin Q; Song J; Xu B
Dig Surg; 2021; 38(1):24-29. PubMed ID: 33171467
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
[TBL] [Abstract][Full Text] [Related]
10. Surgeon-related factors and outcome in rectal cancer.
Porter GA; Soskolne CL; Yakimets WW; Newman SC
Ann Surg; 1998 Feb; 227(2):157-67. PubMed ID: 9488510
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy.
Zhang LN; Xiao W; OuYang PY; You K; Zeng ZF; Ding PR; Pan ZZ; Xu RH; Gao YH
Tumour Biol; 2015 Sep; 36(10):8213-9. PubMed ID: 25994571
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of overall survival and cancer-specific survival in patients with resected early-stage rectal adenocarcinoma: a SEER-based study.
Lee KC; Chung KC; Chen HH; Liu CC; Lu CC
J Investig Med; 2017 Dec; 65(8):1148-1154. PubMed ID: 28735257
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer.
Jiang DM; Raissouni S; Mercer J; Kumar A; Goodwin R; Heng DY; Tang PA; Doll C; MacLean A; Powell E; Price-Hiller J; Monzon J; Cheung WY; Vickers MM
Ann Oncol; 2015 Oct; 26(10):2102-6. PubMed ID: 26232491
[TBL] [Abstract][Full Text] [Related]
14. [Retrospective analysis of 856 cases with stage 0 to III rectal cancer underwent curative surgery combined modality therapy].
Chen P; Yao Y; Zhao J; Li M; Peng Y; Zhan T; Du C; Wang L; Chen N; Gu J
Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):496-501. PubMed ID: 26359071
[TBL] [Abstract][Full Text] [Related]
15. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy.
Yu SK; Chand M; Tait DM; Brown G
Eur J Cancer; 2014 Mar; 50(5):920-7. PubMed ID: 24440086
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer.
Sohn DK; Han KS; Kim BC; Hong CW; Chang HJ; Baek JY; Kim MJ; Park SC; Oh JH; Kim DY
Surg Oncol; 2017 Dec; 26(4):453-459. PubMed ID: 29113665
[TBL] [Abstract][Full Text] [Related]
19. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009.
Cho MM; Morgan JW; Knutsen R; Oda K; Shavlik D; Knutsen S; Kazanjian K
Dis Colon Rectum; 2013 Dec; 56(12):1357-65. PubMed ID: 24201389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
